Takashi Nojiri Selected Research

Takashi Nojiri Research Topics

Disease

18	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2010
13	Neoplasms (Cancer) 01/2022 - 01/2015
7	Neoplasm Metastasis (Metastasis) 12/2019 - 03/2015
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2012
5	Atrial Fibrillation 11/2015 - 04/2010
4	Adenocarcinoma 01/2017 - 11/2010
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017 - 10/2015
3	Agranulocytosis (Granulocytopenia) 12/2023 - 01/2016
3	Acute Lung Injury 01/2018 - 10/2014
3	Inflammation (Inflammations) 01/2017 - 02/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2018 - 01/2017
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2018
2	Heart Failure 01/2017 - 01/2016
2	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2016 - 10/2015
1	Colorectal Neoplasms (Colorectal Cancer) 08/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Pulmonary Hypertension 01/2019
1	Neuroblastoma 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017
1	Insulin Resistance 01/2017
1	Obesity 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Disease Progression 01/2017
1	Cerebral Cavernous Malformations 2 01/2017
1	Rhabdomyosarcoma 01/2016
1	Acute Kidney Injury (Acute Renal Failure) 01/2015
1	Necrosis 01/2015
1	Pneumonia (Pneumonitis) 10/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2014

Drug/Important Bio-Agent (IBA)

16	Atrial Natriuretic Factor (ANF)IBA 12/2023 - 04/2010
6	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 01/2017 - 04/2015
6	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2015 - 04/2010
5	LipopolysaccharidesIBA 01/2018 - 10/2014
5	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2015
3	Tiotropium Bromide (Spiriva)FDA Link 01/2022 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2018 - 02/2016
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2017 - 10/2015
2	Peptides (Polypeptides)IBA 01/2020 - 01/2017
2	landiololIBA 12/2019 - 12/2011
2	CytokinesIBA 01/2019 - 02/2016
2	CollagenIBA 04/2018 - 02/2016
2	E-SelectinIBA 01/2018 - 03/2015
2	Hormones (Hormone)IBA 09/2017 - 01/2016
2	C-Reactive ProteinIBA 04/2017 - 02/2014
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020
1	AntigensIBA 01/2020
1	EpitopesIBA 01/2020
1	AntibodiesIBA 01/2020
1	Interleukin-13IBA 01/2019
1	Interleukin-7 (Interleukin 7)IBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	Interleukin-12 (IL 12)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Interleukin-5 (Interleukin 5)IBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Interleukin-9 (Interleukin 9)IBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Interleukin-4 (Interleukin 4)IBA 01/2019
1	Vincristine (Oncovin)FDA LinkGeneric 01/2018
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2018
1	Angiotensin IIIBA 01/2018
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018
1	PeriostinIBA 01/2018
1	Valsartan (Vals)FDA Link 01/2018
1	RNA (Ribonucleic Acid)IBA 09/2017
1	Laminin ReceptorsIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Cyclic GMPIBA 01/2017
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2017
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2017
1	Carboplatin (JM8)FDA LinkGeneric 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2017
1	Natriuretic PeptidesIBA 01/2017
1	p21-Activated KinasesIBA 01/2017
1	Phosphodiesterase 3 InhibitorsIBA 01/2017
1	InterleukinsIBA 02/2016
1	Interleukin-6 (Interleukin 6)IBA 02/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016
1	Sildenafil Citrate (Viagra)FDA Link 01/2016
1	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 11/2015
1	olprinoneIBA 11/2015
1	Carcinoembryonic AntigenIBA 02/2014
1	Biomarkers (Surrogate Marker)IBA 02/2014

Therapy/Procedure

5	Perioperative Period 12/2019 - 07/2013
4	Therapeutics 01/2020 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2018 - 01/2017
1	Self Expandable Metallic Stents 08/2020
1	Immunotherapy 01/2020
1	Adjuvant Chemotherapy 04/2018
1	Operative Surgical Procedures 11/2010
1	Segmental Mastectomy (Lumpectomy) 04/2010